BIANCHI, FRANCESCA
BIANCHI, FRANCESCA
Dipartimento di Scienze Biomediche per la Salute
SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness
2024 I. Rybinska, N. Mangano, S.L. Romero-Cordoba, V. Regondi, V. Ciravolo, L. De Cecco, E. Maffioli, B. Paolini, F. Bianchi, L. Sfondrini, G. Tedeschi, R. Agresti, E. Tagliabue, T. Triulzi
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures
2024 F. Fontana, M. Sommariva, M. Anselmi, F. Bianchi, P. Limonta, N. Gagliano
Dipeptidyl Peptidase-4 Inhibitor Linagliptin Attenuates Endotoxemia-Activated Inflammasome in Visceral Adipose Tissue of Mice Fed a High Fat Diet
2024 E. Dozio, F. Bianchi, F. Bandera, E. Vianello, L. Tacchini, M.M. Corsi Romanelli
The impact of the extent of the type of primary breast cancer (BC) surgery from the analysis of historical Italian trials
2023 E. Biganzoli, F. Bianchi, P. Boracchi, G. Biganzoli, G. Marano, E. Tagliabue, C. Desmedt, R. Demicheli
Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development
2023 V. Bollati, P. Monti, D. Biganzoli, G. Marano, C. Favero, S. Iodice, L. Ferrari, L. Dioni, F. Bianchi, A.C. Pesatori, E.M. Biganzoli
Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness
2023 G. Bernardo, V. Le Noci, E. Ottaviano, L. De Cecco, C. Camisaschi, S. Guglielmetti, M. Di Modica, G. Gargari, F. Bianchi, S. Indino, P. Sartori, E. Borghi, M. Sommariva, E. Tagliabue, T. Triulzi, L. Sfondrini
HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer
2022 T. Triulzi, V. Regondi, E. Venturelli, P. Gasparini, C. Ghirelli, J. Groppelli, M. DI MODICA, F. Bianchi, L. de cecco, L. Sfondrini, E. Tagliabue
Mechanical cues, E-cadherin expression and cell sociality are crucial crossroads in determining pancreatic ductal adenocarcinoma cells behavior
2022 F. Bianchi, M. Sommariva, L. Cornaghi, L. Denti, A. Nava, F. Arnaboldi, C. Moscheni, N. Gagliano
Live or Heat-Killed Lactobacillus rhamnosus Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model
2022 V. Le Noci, G. Bernardo, G. Manenti, G. Infante, D. Khaleghi Hashemian, L. Minoli, S. Canesi, F. Bianchi, T. Triulzi, S. Arioli, L. De Cecco, S. Guglielmetti, F. Ambrogi, C. Recordati, N. Gagliano, E. Tagliabue, M. Sommariva, L. Sfondrini
Polyphenols–gut–heart : an impactful relationship to improve cardiovascular diseases
2022 F. Bianchi, A. Cappella, N. Gagliano, L. Sfondrini, A. Stacchiotti
Antibiotics treatment impairs the growth of murine triple negative mammary tumors by altering the tumor associated microbiota
2021 V.M. LE NOCI, E. Ottaviano, G. Bernardo, C. Camisaschi, T. Triulzi, S.D. Guglielmetti, M. Di Modica, P.M. Sartori, F. Bianchi, S.L. Indino, M. Sommariva, E. Borghi, E. Tagliabue, L. Sfondrini
Toll like receptors as sensors of the tumor microbial dysbiosis : implications in cancer progression
2021 V. Le Noci, G. Bernardo, F. Bianchi, E. Tagliabue, M. Sommariva, L. Sfondrini
Macrophages impair TLR9 agonist antitumor activity through interacting with the anti-PD-1 antibody Fc domain
2021 S. Camelliti, V. Le Noci, F. Bianchi, C. Storti, F. Arnaboldi, A. Cataldo, S. Indino, E. Jachetti, M. Figini, M.P. Colombo, A. Balsari, N. Gagliano, E. Tagliabue, L. Sfondrini, M. Sommariva
Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer
2021 M. Di Modica, G. Gargari, V. Regondi, A. Bonizzi, S. Arioli, B. Belmonte, L. De Cecco, E. Fasano, F. Bianchi, A. Bertolotti, C. Tripodo, L. Villani, F. Corsi, S. Guglielmetti, A. Balsari, T. Triulzi, E. Tagliabue
Aerosol 1,25-dihydroxyvitamin D3 supplementation: A strategy to boost anti-tumor innate immune activity
2021 F. Bianchi, M. Sommariva, V. Le Noci, S. Camelliti, N. Gagliano, M. Giussani, A. Balsari, E. Tagliabue, L. Sfondrini
TLR3 expression induces apoptosis in human non‐small‐cell lung cancer
2020 F. Bianchi, S. Alexiadis, C. Camisaschi, M. Truini, G. Centonze, M. Milione, A. Balsari, E. Tagliabue, L. Sfondrini
Targeting Local Microbiota by Antibiotic Therapy Promotes Immunosurveillance against Cancer
2020 L. Sfondrini, V. Le Noci, M. Sommariva, F. Bianchi, S. Camelliti, A. Balsari, E. Tagliabue
Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know
2020 S. Camelliti, V. Le Noci, F. Bianchi, C. Moscheni, F. Arnaboldi, N. Gagliano, A. Balsari, M.C. Garassino, E. Tagliabue, L. Sfondrini, M. Sommariva
Deep Into Breast Cancer Heterogeneity to Increase Immunotherapeutic Effectiveness
2020 S. Romero-Cordoba, E. Tagliabue, T. Triulzi, F. Bianchi
Extracellular matrix features discriminate aggressive HER2-positive breast cancer patients who benefit from trastuzumab treatment
2020 I. Rybinska, M. Sandri, F. Bianchi, R. Orlandi, L. De Cecco, P. Gasparini, M. Campiglio, B. Paolini, L. Sfondrini, E. Tagliabue, T. Triulzi